Novel Antigens for Cancer Immunotherapies: A New Era in Oncology

Speaker: Harpreet Singh

H. Singh emphisises that novel antigens will open new horizons in cancer immunotherapies. He covers a new research method and possibilities for antigens discovery and stresses the importance of further research in the field. In particular, he believes the future is in the potential for personalising the therapies for rare antigens, e.g. in glioblastoma.

Discussion points

  • Where are we in the research for novel cancer antigens?
  • What cancer types could benefit from cancer immunotherapies?
  • The future of personalising vaccines to treat cancer patients; the case of glioblastomas